selegiline has been researched along with Adrenocortical Hyperfunction in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Braddock, JA; Church, DB; Robertson, ID; Watson, AD | 1 |
Bruyette, DS; Ruehl, WW; Smidberg, TL | 1 |
Bruyette, DS; Darling, L; Entriken, T; Griffin, D; Ruehl, WW | 1 |
2 review(s) available for selegiline and Adrenocortical Hyperfunction
Article | Year |
---|---|
Canine pituitary-dependent hyperadrenocorticism: a spontaneous animal model for neurodegenerative disorders and their treatment with 1-deprenyl.
Topics: Adrenocortical Hyperfunction; Animals; Disease Models, Animal; Dogs; Dopamine; Nerve Degeneration; Pituitary Gland; Selegiline | 1995 |
Management of canine pituitary-dependent hyperadrenocorticism with l-deprenyl (Anipryl).
Topics: Adrenal Cortex Diseases; Adrenocortical Hyperfunction; Aging; Animals; Dog Diseases; Dogs; Dopamine; Dose-Response Relationship, Drug; Monoamine Oxidase Inhibitors; Pituitary Gland; Selegiline | 1997 |
1 trial(s) available for selegiline and Adrenocortical Hyperfunction
Article | Year |
---|---|
Inefficacy of selegiline in treatment of canine pituitary-dependent hyperadrenocorticism.
Topics: Administration, Oral; Adrenal Cortex Function Tests; Adrenocortical Hyperfunction; Animals; Dog Diseases; Dogs; Female; Male; Neuroprotective Agents; Prospective Studies; Selegiline; Surveys and Questionnaires; Treatment Outcome | 2004 |